With the release of the 2020 – 2024 Strategic Plan, the NPF Research Team reaffirmed its commitment to lead collaborative, transformational research in psoriatic disease by defining four focus area benchmarks:
- Generate research resulting in higher numbers of patients in remission and identify tools to extend remission periods.
- Fund a diagnostic test for psoriatic arthritis (PsA) that has broad clinical utility, with the test having been developed, tested, and approved for use.
- Identify a reliable, predictive model for onset of psoriatic disease, the potential relationship to comorbid conditions and the best treatment practices for a cure.
- Establish a multi‐institution, multi‐disciplinary, team‐based, virtual cluster whose stated aim is to identify an intervention that will prevent the onset of psoriatic disease or its comorbidities.